ProKidney Corp. (PROK)
1.975
-0.10
(-5.05%)
USD |
NASDAQ |
Mar 19, 14:01
ProKidney EPS Diluted (Quarterly) : -0.122 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lineage Cell Therapeutics, Inc. | 0.0035 |
| Aquestive Therapeutics, Inc. | -0.2612 |
| Nautilus Biotechnology, Inc. | -0.109 |
| Neumora Therapeutics, Inc. | -0.3507 |
| Korro Bio, Inc. | -5.321 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -35.84M |
| Revenue (Quarterly) | 0.217M |
| Total Expenses (Quarterly) | 16.69M |
| Enterprise Value | 1.353B |
| Gross Profit Margin (Quarterly) | -544.2% |
| Profit Margin (Quarterly) | -16.52K% |
| Earnings Yield | -27.57% |
| Normalized Earnings Yield | -26.10 |